State of the art in thoracic oncology

At the end of the course, participants:

Will have recent knowledge update on diagnosis, staging, and therapy of thoracic malignancies.
Will have case-based experience with opinion leaders in help of their current practice.

+ show speakers and program
Thursday, 22 November 2012
Session I : Screening, diagnosis and staging of lung cancer
Chairs: Gamarra/Schönfeld
10:30 – 10:35 Introduction J. Vansteenkiste F. Gamarra B. Grigoriu
10:35 – 10:55 Current status of lung cancer screening F. Herth
10:55 – 11:25 Role of imaging in diagnosis & staging (incl. SPN assessment) J. Vansteenkiste
11:25 – 11:55 Role of endoscopy in diagnosis and staging F Herth
11:55 – 12:15 Coffee
12:15 – 12:45 Clinical pearls in diagnosis and staging F. Herth J. Vansteenkiste
12:45 – 13:00 Discussion and Q&A of morning session
13:00 – 14:00 Lunch
Session II – Treatment of advanced lung cancer
Chairs: Huber/Scherpereel
14:00 – 14:30 Histology and biomarkers P. Schnabel
14:30 – 14:45 Discussion and Q&A
14:45 – 15:15 First-line treatment of advanced NSCLC J. Vansteenkiste
15:15 – 15:45 Maintenance and relapse treatment for NSCLC F. Gamarra
15:45 – 16:05 Coffee Break
16:05 – 16:35 Clinical pearls in treatment of advanced NSCLC P. Schnabel, J. Vansteenkiste F.
Gamarra
16:35 – 16:55 Systemic treatment of SCLC JP Sculier
16:55 – 17:15 Clinical pearls in treatment of SCLC JP Sculier
17:15 – 17:30 Discussion and Q&A of afternoon session
Friday, 23 November 2012
Session III – Treatment of early stage lung cancer
Chairs: Herth/Vansteenkiste
09:00 – 09:20 Functional evaluation for radical therapy F. Gamarra
09:20 – 09:40 Clinical pearls in functional evaluation F. Gamarra
09:40 – 10:10 Contemporary thoracic surgery (incl. anatomic resection, organ sparing resection,
VATS, LN dissection, etc…) D. Subotic
10:10 – 10:40 Role of adjuvant and neo-adjuvant therapy JP Sculier
10:40 – 11:00 Coffee Break
11:00 -11:30 Non-surgical therapy for early stage lung cancer (radiotherapy, RFA, etc…) P. Van
Houtte
11:30 -12:00 Clinical pearls in early stage lung cancer D. Subotic, JP Sculier F. Gamarra
12:00 - 12:15 Discussion and Q&A of early stage lung cancer
Session IV – Treatment of locally advanced lung cancer
Chairs: Sculier/Vansteenkiste
12:15 – 12:45 The role of surgery in locally advanced NSCLC (incl. the role of surgery in staging, the
IIIA-N2, pancoast,…) D. Subotic
12:45 – 13:45 Lunch
13:45 - 14:15 Chemoradiotherapy for NSCLC R. Huber
14:15 – 14:35 Overview of management of multimodality treatments complication P. Van Houtte
14:35 – 15:05 Clinical pearls in locally advanced NSCLC R. Huber P. Van Houtte D. Subotic
15:05 – 15:35 Multimodality approaches for SCLC (incl. PCI) R. Huber
15:35 – 15:55 Clinical pearls in limited disease SCLC R. Huber
15:55 – 16:15 Coffee
Session V – Care and communication
Chairs: Grigoriu/Van Houtte
16:15 – 16:40 Supportive care and symptom control N. Schönfeld
16:40 – 17:05 Palliative care and communication skills N. Schönfeld
17:05 – 17:20 Discussion and Q&A of afternoon session
Saturday, 24 November 2012
Session VI : Pleural malignancies
Chairs: Subotic/Van Houtte
09:00 – 09:30 Diagnostic approach to malignant pleural effusions (imaging, endoscopy) B. Grigoriu
09:30 – 10:10 Medical management of pleural malignancies (chemo, supp care) A. Scherpereel
10:10 – 10:30 Multimodality approaches for malignant mesothelioma A. Scherpereel
10:30 – 11:00 Clinical pearls in malignant pleural disease B. Grigoriu A. Scherpereel
11:00 – 11:20 Coffee Break
Session VII : Rare thoracic malignancies
Chairs: Schnabel/Schönfeld
11:20 – 11:40 Neuro-endocrine tumours (focus on other than SCLC) F. Schnabel
11:40 – 12:00 Mediastinal tumours B. Grigoriu
12:00 – 12:20 Clinical pearls in rare thoracic malignancies F. Schnabel B. Grigoriu
12:20 – 12:35 Discussion and Q&A

22 Nov - 24 Nov 2012

Berlin
Germany
meeting website